Preservation of Endogenous Antioxidant Activity and Inhibition of Lipid Peroxidation as Common Mechanisms of Antiatherosclerotic Effects of Vitamin E, Lovastatin and Amlodipine
- 1 August 1997
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 30 (2) , 569-575
- https://doi.org/10.1016/s0735-1097(97)00158-7
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Lipids and oxidised lipids in human atherosclerotic lesions at different stages of developmentBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1995
- Anti-atheromatous effects of fenofibrate, a hypolipidemic drug. II. Anti-atheromatous effects are independent of its hypolipidemic effect in hereditary hyperlipidemic rabbits.Folia Pharmacologica Japonica, 1995
- Increase in Intracellular Calcium Ion in Smooth Muscle Cells Induced by Low-Density LipoproteinGerontology, 1994
- Effects of Etidronate and Lovastatin on the Regression of Atherosclerosis in Cholesterol-Fed RabbitsCardiology, 1994
- Simvastatin inhibits the oxidation of low-density lipoproteins by activated human monocyte-derived macrophagesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1993
- Effect of vitamin E on acute iron load-potentiated aggregation, secretion, calcium uptake and thromboxane biosynthesis in rat plateletsAtherosclerosis, 1992
- Low density lipoprotein inhibits accumulation of nitrites in murine brain endothelial cell culturesBiochemical and Biophysical Research Communications, 1992
- Endothelial cell interactions with granulocytes: tethering and signaling moleculesImmunology Today, 1992
- LovastatinDrugs, 1988
- HMG-CoA Reductase Inhibitors for Treatment of HypercholesterolemiaNew England Journal of Medicine, 1988